Insider Trading activities of Co insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Co since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Co since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Co since 2005. The reporting company's ticker symbol is LLY. The reporting company's CIK number is 59478.
The total value of stock buying since 2005 is $2,605,998.
The total value of stock sales since 2005 is $2,373,697,787.
The total value of stock option exercises since 2005 is $40,933,407.


 1   2   3 

Table 2. Detailed insider stock purchases, sales, and option exercises of Co insiders (LLY) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-10-01 Zulueta Alfonso G (SVP& Pres., Emerging Markets) Option Ex 9,333 .00 0
2014-10-01 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Sale 5,000 64.86 324,300
2014-09-30 Lilly Endowment Inc (10% Owner) Sale 200,000 65.07 13,013,999
2014-09-12 Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) Option Ex 2,941 55.91 164,446
2014-09-10 Lilly Endowment Inc (10% Owner) Sale 210,000 64.77 13,601,700
2014-09-08 Ricks David A (SVP and Pres, Lilly Bio-Meds) Option Ex 1,509 55.65 83,975
2014-09-04 Rice Derica W (EVP-Global Services and CFO) Option Ex 23,077 55.65 1,284,235
2014-09-03 Lilly Endowment Inc (10% Owner) Sale 200,000 63.99 12,798,000
2014-09-02 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Sale 5,000 63.60 318,000
2014-08-26 Fry Stephen F (SVP, HR & Diversity) Option Ex 8,380 55.91 468,567
2014-08-13 Mahony Susan (SVP & Pres., Lilly Oncology) Option Ex 8,521 55.65 474,193
2014-08-12 Harrington Michael J (Senior VP and General Counsel) Option Ex 2,722 55.65 151,479
2014-07-29 Lilly Endowment Inc (10% Owner) Sale 250,000 63.34 15,833,750
2014-07-28 Mahony Susan (SVP & Pres., Lilly Oncology) Sale 2,065 63.30 130,714
2014-07-28 Mahony Susan (SVP & Pres., Lilly Oncology) Option Ex 2,240 .00 0
2014-07-25 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Sale 10,000 63.79 637,900
2014-07-25 Mahony Susan (SVP & Pres., Lilly Oncology) Sale 30,000 63.90 1,917,000
2014-07-01 Lilly Endowment Inc (10% Owner) Sale 235,000 62.30 14,640,500
2014-06-25 Lilly Endowment Inc (10% Owner) Sale 245,000 62.89 15,408,050
2014-06-20 Lilly Endowment Inc (10% Owner) Sale 230,000 61.63 14,174,900
2014-06-16 Lilly Endowment Inc (10% Owner) Sale 200,000 58.73 11,746,000
2014-06-05 Lilly Endowment Inc (10% Owner) Sale 190,000 59.53 11,310,700
2014-05-21 Lilly Endowment Inc (10% Owner) Sale 230,000 58.90 13,547,000
2014-05-12 Tai Jackson P Buy 17,157 59.16 1,015,093
2014-05-12 Lilly Endowment Inc (10% Owner) Sale 210,000 59.33 12,459,300
2014-05-06 Lilly Endowment Inc (10% Owner) Sale 190,000 59.14 11,236,600
2014-04-29 Lilly Endowment Inc (10% Owner) Sale 200,000 59.43 11,886,000
2014-04-28 Lilly Endowment Inc (10% Owner) Sale 150,000 58.64 8,796,000
2014-02-03 Ricks David A (SVP and Pres, Lilly Bio-Meds) Sale 3,086 .00 0
2014-02-03 Rice Derica W (EVP-Global Services and CFO) Sale 16,562 .00 0
2014-02-01 Fry Stephen F (SVP, HR & Diversity) Option Ex 9,405 .00 0
2014-02-01 Lundberg Jan M (EVP,Science&Tech and Pres. LRL) Option Ex 21,552 .00 0
2014-02-01 Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) Option Ex 9,405 .00 0
2014-02-01 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Option Ex 15,674 .00 0
2014-02-01 Peterson Barton R (Sr. VP, Corp. Affairs & Comm.) Option Ex 7,837 .00 0
2014-02-01 Mahony Susan (SVP & Pres., Lilly Oncology) Option Ex 14,107 .00 0
2014-02-01 Rice Derica W (EVP-Global Services and CFO) Option Ex 29,781 .00 0
2014-02-01 Lechleiter John C (Chairman, President and CEO) Option Ex 58,778 .00 0
2014-01-31 Tai Jackson P Buy 12,431 .00 0
2013-11-04 Mahony Susan (Senior VP, Human Resources) Option Ex 4,056 .00 0
2013-08-15 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Sale 5,000 53.79 268,950
2013-07-29 Tapiero Jacques (SVP&Pres., Emerging Markets) Sale 7,500 53.74 403,050
2013-07-15 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Sale 5,000 51.43 257,150
2013-06-17 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Sale 5,000 52.45 262,250
2013-05-15 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Sale 5,000 56.15 280,750
2013-05-10 Simmons Jeffrey N (SVP&Pres.,Elanco Animal Health) Sale 10,000 54.49 544,900
2013-05-01 Simmons Jeffrey N (SVP&Pres.,Elanco Animal Health) Option Ex 10,000 .00 0
2013-05-01 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Option Ex 10,000 .00 0
2013-04-29 Mahony Susan (SVP & Pres., Lilly Oncology) Sale 3,500 56.33 197,155
2013-04-15 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Sale 5,000 57.10 285,500
2013-03-26 Mahony Susan (SVP & Pres., Lilly Oncology) Sale 5,000 56.00 280,000
2013-03-12 Lundberg Jan M (EVP,Science&Tech and Pres. LRL) Sale 19,000 55.38 1,052,220
2013-02-08 Ricks David A (SVP and Pres, Lilly Bio-Meds) Sale 3,000 53.91 161,730
2013-02-05 Rice Derica W (EVP-Global Services and CFO) Sale 29,646 54.21 1,607,109
2013-02-01 Lundberg Jan M (EVP,Science&Tech and Pres. LRL) Option Ex 77,456 .00 0
2013-02-01 Simmons Jeffrey N (SVP&Pres.,Elanco Animal Health) Option Ex 17,649 .00 0
2013-02-01 Tapiero Jacques (SVP&Pres., Emerging Markets) Option Ex 17,649 .00 0
2013-02-01 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Option Ex 31,768 .00 0
2013-02-01 Peterson Barton R (Sr. VP, Corp. Affairs & Comm.) Option Ex 14,119 .00 0
2013-02-01 Mahony Susan (SVP & Pres., Lilly Oncology) Sale 5,000 54.28 271,400
2013-02-01 Mahony Susan (SVP & Pres., Lilly Oncology) Option Ex 22,943 .00 0
2013-02-01 Rice Derica W (EVP-Global Services and CFO) Option Ex 52,947 .00 0
2013-02-01 Lechleiter John C (Chairman, President, and CEO) Option Ex 132,367 .00 0
2013-01-30 Tapiero Jacques (SVP&Pres., Emerging Markets) Sale 15,000 54.14 812,100
2012-12-03 Zakrowski Donald A (Chief Accounting Officer) Option Ex 1,641 .00 0
2012-12-03 Ricks David A (SVP and Pres, Lilly Bio-Meds) Option Ex 2,748 .00 0
2012-12-03 Fry Stephen F (SVP, HR & Diversity) Option Ex 3,778 .00 0
2012-10-24 Mahony Susan (SVP & Pres., Lilly Oncology) Sale 10,000 50.45 504,500
2012-10-01 Tapiero Jacques (SVP&Pres., Emerging Markets) Option Ex 12,500 .00 0
2012-08-01 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Sale 5,000 44.16 220,799
2012-07-02 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Sale 5,000 43.00 215,000
2012-06-14 Tapiero Jacques (SVP&Pres., Emerging Markets) Sale 2,125 41.60 88,400
2012-06-01 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Sale 5,000 40.60 203,000
2012-05-18 Hanish Arnold C (Chief Accounting Officer) Sale 1,295 40.49 52,434
2012-05-14 Tapiero Jacques (SVP&Pres., Emerging Markets) Sale 2,000 41.04 82,080
2012-05-01 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Sale 5,000 41.32 206,600
2012-04-17 Tapiero Jacques (SVP&Pres., Emerging Markets) Sale 2,000 40.00 80,000
2012-03-12 Tapiero Jacques (SVP&Pres., Emerging Markets) Sale 2,000 39.60 79,200
2012-02-13 Simmons Jeffrey N (SVP&Pres.,Elanco Animal Health) Sale 7,900 38.85 306,915
2012-02-02 Rice Derica W (EVP-Global Services and CFO) Sale 3,800 39.61 150,518
2012-02-01 Lundberg Jan M (EVP,Science&Tech and Pres. LRL) Option Ex 33,333 .00 0
2012-02-01 Peterson Barton R (Sr. VP, Corp. Affairs & Comm.) Option Ex 16,474 .00 0
2012-02-01 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Option Ex 87,924 .00 0
2012-02-01 Deane Frank M (President, Mfg. Operations) Option Ex 37,368 .00 0
2012-02-01 Rice Derica W (EVP-Global Services and CFO) Sale 17,584 39.85 700,722
2012-02-01 Rice Derica W (EVP-Global Services and CFO) Option Ex 87,924 .00 0
2012-02-01 Armitage Robert A (Sr. VP and General Counsel) Option Ex 58,616 .00 0
2012-02-01 Lechleiter John C (Chairman, President, and CEO) Option Ex 219,812 .00 0
2011-12-12 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 5,787 39.10 226,271
2011-11-18 Tapiero Jacques (SVP&Pres., Emerging Markets) Sale 5,000 36.88 184,400
2011-11-11 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 5,700 37.55 214,034
2011-10-11 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 5,700 38.10 217,170
2011-10-02 Walsh Fionnuala M (SVP, Global Quality) Option Ex 1,880 .00 0
2011-10-01 Tapiero Jacques (SVP&Pres., Emerging Markets) Option Ex 12,500 .00 0
2011-09-12 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 5,700 35.91 204,686
2011-08-31 Simmons Jeffrey N (SVP&Pres.,Elanco Animal Health) Option Ex 3,278 .00 0
2011-08-11 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 5,700 33.94 193,458
2011-07-11 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 5,700 37.39 213,123
2011-07-06 Deane Frank M (President, Mfg. Operations) Sale 5,000 37.20 186,000
2011-06-27 Deane Frank M (President, Mfg. Operations) Sale 5,000 36.73 183,675
2011-06-20 Deane Frank M (President, Mfg. Operations) Sale 5,000 37.38 186,900
2011-06-13 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 5,700 37.25 212,325
2011-05-17 Hanish Arnold C (Chief Accounting Officer) Sale 3,378 39.12 132,147
2011-05-11 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 5,700 38.21 217,797
2011-04-20 Nobles Anne (Chief Eth/Cmpl Ofcr & SVP, ERM) Sale 12,000 35.98 431,759
2011-04-11 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 5,700 35.76 203,832
2011-03-11 Lundberg Jan M (EVP,Science&Tech and Pres. LRL) Sale 11,000 34.86 383,460
2011-03-04 Tapiero Jacques (SVP&Pres., Emerging Markets) Sale 5,000 34.50 172,500
2011-02-16 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 3,100 34.49 106,919
2011-02-15 Rice Derica W (EVP-Global Services and CFO) Sale 12,441 34.55 429,836
2011-02-09 Deane Frank M (President, Mfg. Operations) Sale 23,435 35.75 837,801
2011-02-03 Armitage Robert A (Sr. VP and General Counsel) Sale 35,194 35.34 1,243,931
2011-02-01 Lundberg Jan M (EVP,Science&Tech and Pres. LRL) Option Ex 33,333 .00 0
2011-02-01 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Option Ex 82,942 .00 0
2011-02-01 Deane Frank M (President, Mfg. Operations) Option Ex 35,250 .00 0
2011-02-01 Rice Derica W (EVP-Global Services and CFO) Option Ex 82,942 .00 0
2011-02-01 Armitage Robert A (Sr. VP and General Counsel) Option Ex 55,294 .00 0
2011-02-01 Lechleiter John C (Chairman, President, and CEO) Option Ex 207,354 .00 0
2011-01-14 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 3,100 34.87 108,096
2010-12-16 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 3,100 35.10 108,810
2010-11-16 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 3,100 34.43 106,733
2010-10-15 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 3,100 37.65 116,715
2010-09-16 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 3,100 35.55 110,204
2010-08-16 Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds) Sale 3,100 35.33 109,523
2010-03-11 Tapiero Jacques (SVP&Pres., Emerging Markets) Sale 4,000 35.41 141,620
2010-03-02 Nobles Anne (Chief Eth/Cmpl Ofcr & SVP, ERM) Sale 4,811 34.71 166,989
2010-02-17 Tapiero Jacques (SVP&Pres., Emerging Markets) Sale 2,000 34.35 68,700
2010-02-03 Rice Derica W (EVP-Global Services and CFO) Sale 8,200 35.26 289,140
2010-02-01 Carmine Bryce D. (EVP and Pres, Est Markets BU) Option Ex 51,249 .00 0
2010-02-01 Deane Frank M (President, Mfg. Operations) Option Ex 18,877 .00 0
2010-02-01 Rice Derica W (EVP-Global Services and CFO) Option Ex 40,999 .00 0
2010-02-01 Paul Steven M (EVP, Science and Technology) Option Ex 51,249 .00 0
2010-02-01 Armitage Robert A (Sr. VP and General Counsel) Option Ex 29,213 .00 0
2010-02-01 Lechleiter John C (Chairman, President, and CEO) Option Ex 111,041 .00 0
2009-11-20 Hanish Arnold C (Chief Accounting Officer) Sale 2,673 36.65 97,965
2008-09-09 Lilly Endowment Inc (10% Owner) Sale 130,000 47.31 6,094,974
2008-09-02 Lilly Endowment Inc (10% Owner) Sale 165,000 46.92 7,737,055
2008-08-28 Lilly Endowment Inc (10% Owner) Sale 160,000 46.89 7,501,506
2008-08-25 Lilly Endowment Inc (10% Owner) Sale 120,000 47.60 5,719,319
2008-08-22 Lilly Endowment Inc (10% Owner) Sale 150,000 47.86 7,165,549
2008-08-15 Lilly Endowment Inc (10% Owner) Sale 155,000 48.86 7,562,597
2008-08-12 Lilly Endowment Inc (10% Owner) Sale 110,000 49.40 5,432,488
2008-08-11 Lilly Endowment Inc (10% Owner) Sale 80,000 48.87 3,924,891
2008-08-08 Lilly Endowment Inc (10% Owner) Sale 115,000 48.31 5,562,930
2008-08-06 Lilly Endowment Inc (10% Owner) Sale 90,000 47.74 4,309,772
2008-08-05 Lilly Endowment Inc (10% Owner) Sale 140,000 47.71 6,667,371
2008-08-04 Lilly Endowment Inc (10% Owner) Sale 120,000 47.41 5,686,363
2008-07-30 Lilly Endowment Inc (10% Owner) Sale 90,000 47.48 4,291,182
2008-07-29 Lilly Endowment Inc (10% Owner) Sale 110,000 48.31 5,313,878
2008-07-28 Lilly Endowment Inc (10% Owner) Sale 100,000 47.99 4,783,511
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of LLY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Co (symbol LLY, CIK number 59478) see the Securities and Exchange Commission (SEC) website.